Form4insider filings, from the source

SEC Form 4 · accession 0001415889-16-004378

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Inc/il Bvf
10% Owner
BVF Partners OS Ltd.
10% Owner · Other
Period of report
Jan 7, 2016
Accepted (ET)
Jan 11, 2016 · 8:17 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, no par value per shareF1,F2Jan 7, 2016P508,287$1.2171A15,405,846D
Common Stock, no par value per shareF1,F3Jan 7, 2016P87,747$1.2171A8,760,787D
Common Stock, no par value per shareF1,F4Jan 7, 2016P29,655$1.2171A3,058,173D
Common Stock, no par value per shareF1,F5Jan 7, 2016P8,091$1.2171A17,204,587IPlease see footnote
Common Stock, no par value per shareF1,F2Jan 8, 2016P186,314$1.2171A15,592,160D
Common Stock, no par value per shareF1,F3Jan 8, 2016P90,049$1.2171A8,850,836D
Common Stock, no par value per shareF1,F4Jan 8, 2016P32,571$1.2171A3,090,744D
Common Stock, no par value per shareF1,F5Jan 8, 2016P58,613$1.2171A17,263,200IPlease see footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses